Clinical decision support to improve management of diabetes and dysglycemia in the hospital: a path to optimizing practice and outcomes
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Introduction: Innovative approaches are needed to design robust clinical decision support (CDS) to optimize hospital glycemic management. We piloted an electronic medical record (EMR), evidence-based algorithmic CDS tool in an academic center to alert clinicians in real time about gaps in care related to inpatient glucose control and insulin utilization, and to provide management recommendations. Research design and methods: The tool was designed to identify clinical situations in need for action: (1) severe or recurrent hyperglycemia in patients with diabetes: blood glucose (BG) ≥13.88 mmol/L (250 mg/dL) at least once or BG ≥10.0 mmol/L (180 mg/dL) at least twice, respectively; (2) recurrent hyperglycemia in patients with stress hyperglycemia: BG ≥10.0 mmol/L (180 mg/dL) at least twice; (3) impending or established hypoglycemia: BG 3.9–4.4 mmol/L (70–80 mg/dL) or ≤3.9 mmol/L (70 mg/dL); and (4) inappropriate sliding scale insulin (SSI) monotherapy in recurrent hyperglycemia, or anytime in patients with type 1 diabetes. The EMR CDS was active (ON) for 6 months for all adult hospital patients and inactive (OFF) for 6 months. We prospectively identified and compared gaps in care between ON and OFF periods. Results: When active, the hospital CDS tool significantly reduced events of recurrent hyperglycemia in patients with type 1 and type 2 diabetes (3342 vs 3701, OR=0.88, p=0.050) and in patients with stress hyperglycemia (288 vs 506, OR=0.60, p<0.001). Hypoglycemia or impending hypoglycemia (1548 vs 1349, OR=1.15, p=0.050) were unrelated to the CDS tool on subsequent analysis. Inappropriate use of SSI monotherapy in type 1 diabetes (10 vs 22, OR=0.36, p=0.073), inappropriate use of SSI monotherapy in type 2 diabetes (2519 vs 2748, OR=0.97, p=0.632), and in stress hyperglycemia subjects (1617 vs 1488, OR=1.30, p<0.001) were recognized. Conclusion: EMR CDS was successful in reducing hyperglycemic events among hospitalized patients with dysglycemia and diabetes, and inappropriate insulin use in patients with type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The addition of noninsulin agents, such as DPP-4 inhibitors or GLP-1 RAs, before admission or during the perioperative period, has not reduced rates of stress hyperglycemia and may increase nausea and vomiting rates1316–1324 among critically ill persons.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1321]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“While the use of these agents is safe and may result in lower glucose levels and insulin doses, we do not recommend addition of a DPP-4 inhibitor or GLP-1 RA to IV insulin therapy until efficacy is demonstrated.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1321]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Controlling the false discovery rate in behavior genetics research
Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N., & Golani, I. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00297-2 · Cited by 4,146
Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Diabetes Care · doi:10.2337/dc09-9029 · Cited by 1,444
Self-citationUmpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
Self-citationUmpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M. (2011) · Diabetes Care · doi:10.2337/dc10-1407 · Cited by 720 · cited 3×
“37 Basal-bolus insulin therapy is the standard of care for patients with type 1 diabetes, and SSI monotherapy is contraindicated in patients with type 1 diabetes due to their absolute insulin dependency and risk for diabetic ketoacidosis.”
BackgroundSelf-citationHealth Information Technology: An Updated Systematic Review With a Focus on Meaningful Use
Jones, S. S., Rudin, R. S., Perry, T., & Shekelle, P. G. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1531 · Cited by 475
Unrecognized Diabetes Among Hospitalized Patients
Levetan, C. S., Passaro, M., Jablonski, K., Kass, M., & Ratner, R. E. (1998) · Diabetes Care · doi:10.2337/diacare.21.2.246 · Cited by 305
15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s015 · Cited by 265
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationTelehealth and Telemedicine - The Far-Reaching Medicine for Everyone and Everywhere
(2023) · Biomedical Engineering · doi:10.5772/intechopen.100663 · Cited by 84
Applications of Clinical Decision Support Systems in Diabetes Care: Scoping Review
Huang, S., Liang, Y., Li, J., & Li, X. (2023) · Journal of Medical Internet Research · doi:10.2196/51024 · Cited by 42
Technology in the management of diabetes in hospitalised adults
Thabit, H., & Schofield, J. D. (2024) · Diabetologia · doi:10.1007/s00125-024-06206-4 · Cited by 34
Clinical Decision Support for Glycemic Management Reduces Hospital Length of Stay
Pichardo-Lowden, A. R., Haidet, P., Umpierrez, G. E., Lehman, E. B., Quigley, F. T., Wang, L., Rafferty, C. M., DeFlitch, C. J., & Chinchilli, V. M. (2022) · Diabetes Care · doi:10.2337/dc21-0829 · Cited by 28
Self-citation
Metadata
- Authors
- Pichardo-Lowden, A., Umpierrez, G., Lehman, E. B., Bolton, M. D., DeFlitch, C. J., Chinchilli, V. M., & Haidet, P. M.
- Affiliations
- Pennsylvania State University (US)
- Emory University (US)
- Corresponding author
- Pichardo-Lowden, Ariana
- Venue
- BMJ Open Diabetes Research & Care
- Publisher
- BMJ
- Published
- 2021-01
- Volume
- 9
- Issue
- 1
- Pages
- e001557
- ISSN
- 2052-4897 (ISSN-L)
- PMC
- PMC7816906
- OpenAlex
- W3123092012
- Cited by
- 30
- References
- 39
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 6 · 2023: 4 · 2022: 8 · 2021: 1
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMJ Open Diabetes Research & Care (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (5K23DK107914-05)
- Eberly Medical Research Innovation Fund (N/A)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Health Professions › Health Information Management › Electronic Health Records Systems
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- clinical decision support, diabetes mellitus, hyperglycemia, hypoglycemia, sliding scale insulin, type 1 diabetes, type 2 diabetes, stress hyperglycemia, electronic health record alerts, care gaps, quality improvement
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Hospitals, Humans, Hypoglycemia, Hypoglycemic Agents, Decision Support Systems, Clinical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical decision support to improve management of diabetes and dysglycemia in the hospital: a path to optimizing practice and outcomes. https://app.cochat.ai/papers/10.1136/bmjdrc-2020-001557
- The paper
- Pichardo-Lowden, A., Umpierrez, G., Lehman, E. B., Bolton, M. D., DeFlitch, C. J., Chinchilli, V. M., & Haidet, P. M. (2021). Clinical decision support to improve management of diabetes and dysglycemia in the hospital: a path to optimizing practice and outcomes. BMJ Open Diabetes Research & Care. https://doi.org/10.1136/bmjdrc-2020-001557
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.